Avalo Therapeutics, Inc. - AVTX

SEC FilingsOur AVTX Tweets

About Gravity Analytica

Recent News

  • 08.27.2025 - Avalo Therapeutics to Participate in Upcoming Investor Conferences
  • 08.07.2025 - Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
  • 06.23.2025 - Avalo Therapeutics to Participate in Upcoming Investor Conferences
  • 06.18.2025 - Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

Recent Filings

  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.07.2025 - 8-K Current report
  • 08.07.2025 - EX-99.1 EX-99.1
  • 08.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 06.20.2025 - 8-K Current report
  • 06.20.2025 - EX-99.1 EX-99.1
  • 06.18.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.18.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.18.2025 - 4 Statement of changes in beneficial ownership of securities